Pliant Therapeutics Inc (PLRX)
11.90
-0.62
(-4.95%)
USD |
NASDAQ |
Apr 24, 16:00
11.89
-0.01
(-0.08%)
After-Hours: 20:00
Pliant Therapeutics Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 9.988M |
| March 31, 2023 | 9.958M |
| December 31, 2022 | 9.929M |
| September 30, 2022 | 9.90M |
| June 30, 2022 | 9.871M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
9.988M
Maximum
Jun 2023
3.310M
Average
--
Median
Dec 2019
Total Long Term Debt (Quarterly) Benchmarks
| Masimo Corp | 906.00M |
| Liquidia Corp | 0.00 |
| Vor Biopharma Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |